1-1 of 1
Deborah A. Casale, MS
Close
Sort by
Journal Articles

A Phase I Open Label Dose Escalation Study To Evaluate MEDI-507 in Patients with CD2-Positive T-Cell Lymphoma/Leukemia.

Deborah A. Casale, MS, Nancy L. Bartlett, MD, David D. Hurd, MD, Francine Foss, MD, Barbara Pro, MD, Lubomir Sokol, MD, PhD, Ronald Lieberman, MD, Hammershaimb Luz, MD
Journal: Blood
Blood (2006) 108 (11): 2727.
https://doi.org/10.1182/blood.V108.11.2727.2727
Published: 2006